Stockscreener 앱 받기
0.7605
5.61%
0.0404
시간 외 거래:
.74
-0.0205
-2.70%
Biofrontera Inc 주식(BFRI)의 최신 뉴스
Biofrontera completes transfer of Ameluz® and Rhodoled® FDA approval - marketscreener.com
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED By Investing.com - Investing.com Australia
Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio - The Manila Times
Photodynamic therapy maker takes over Ameluz and lamp patents - Stock Titan
Aug Levels: Will Biofrontera Inc Equity Warrant stock split attract more investorsPortfolio Performance Summary & AI Enhanced Trading Alerts - moha.gov.vn
What analysts say about Biofrontera Inc AI10 stockContrarian Investment Ideas & Free Daily Top Stock Picks for All Investors - earlytimes.in
Biofrontera (NASDAQ:BFRI) Trading Down 1.5% – Time to Sell? - Defense World
Biofrontera Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Biofrontera completes phase 1 study for expanded Ameluz treatment areas By Investing.com - Investing.com Nigeria
Will Biofrontera Inc. (AI10) stock sustain bullish trend into 2025Market Growth Review & Risk Controlled Swing Alerts - Newser
Why Biofrontera Inc. (AI10) stock attracts HNW investors2025 Big Picture & Safe Entry Momentum Tips - Newser
Why Biofrontera Inc. (AI10) stock is favored by hedge fundsWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - Newser
Will Biofrontera Inc. Equity Warrant stock outperform growth indexes2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel - TipRanks
Biofrontera completes phase 1 study for expanded Ameluz treatment areas - Investing.com
Biofrontera (Nasdaq: BFRI) wraps Ameluz Phase 1 PK trial on trunk, plans 2026 FDA sNDA - Stock Titan
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC - MSN
Can Biofrontera Inc. (AI10) stock survive global slowdownJuly 2025 Update & High Yield Stock Recommendations - Newser
Why Biofrontera Inc. stock remains on buy listsWatch List & Long Hold Capital Preservation Plans - Newser
Biofrontera Inc. (BFRI) 5.8% in After-hours: Filing for New Drug Application Boosts Stock - Stocks Telegraph
Biofrontera submits sNDA to FDA for skin cancer treatment By Investing.com - Investing.com Australia
Biofrontera Inc. (BFRI) 20.51% in After-hours: Notable Price Surge - Stocks Telegraph
Biofrontera submits sNDA to FDA for skin cancer treatment - Investing.com
Biofrontera Inc. announces filing of supplemental new drug application - marketscreener.com
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT - The Manila Times
Why global investors buy Biofrontera Inc. (AI10) stockJuly 2025 Selloffs & AI Enhanced Trading Alerts - Newser
Biofrontera (BFRI) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Biofrontera Inc Equity Warrant stockVWAP Trading Strategies & Small Budget Trading Portfolio - earlytimes.in
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025 - TradingView — Track All Markets
BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025 - TradingView
Biofrontera, Inc. Navigates Mixed Earnings Call - MSN
Biofrontera reports Q3 EPS (62c) vs (98c) last year - MSN
Is Biofrontera Inc. stock a top momentum playJuly 2025 Macro Moves & Growth Focused Stock Reports - BỘ NỘI VỤ
Its Stock Has Paid Off Big Time For Biofrontera Inc - Setenews
Is Biofrontera Inc a good long term investmentInsider Buying Signals & Lower Drawdowns With Smart Position Sizing - earlytimes.in
How interest rate cuts could boost Biofrontera Inc. Equity Warrant stock - BỘ NỘI VỤ
Is National Plywood Industries Limiteds Business Model Sustainable Long TermMarket Capitalization Trends & Receive Monthly Expert Trading Blueprints - earlytimes.in
How reliable is Biofrontera Inc. (AI10) stock dividend growthEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Why Biofrontera Inc. Equity Warrant is moving todayJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Biofrontera Inc. (AI10) stock could outperform next yearJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
News impact scoring models applied to Biofrontera Inc.Weekly Trade Summary & Weekly Hot Stock Watchlists - newser.com
Will Biofrontera Inc. (AI10) stock benefit from commodity supercycleGDP Growth & Safe Entry Trade Reports - newser.com
12.55%
0.77%
자본화:
|
볼륨(24시간):